Expanded Hemodialysis Therapy Market - Top Companies and Manufacturers

  • Report ID: 3372
  • Published Date: Jul 23, 2024
  • Report Format: PDF, PPT

Companies Dominating the Expanded Hemodialysis Therapy Landscape

top-features-companies
    • B. Braun Melsungen AG
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Asahi Kasei Corporation
    • Baxter International, Inc.
    • Fresenius Medical Care AG & Co. KGaA
    • Nikkiso Co., Ltd.
    • Nipro Corporation
    • NxStage Medical, Inc.
    • Cantel Medical Corp.
    • Satellite Healthcare, Inc.
    • MEDIVATORS, Inc. 

Browse Key Market Insights with Data Illustration:

In the News

  • B. Braun Melsungen AG has finally acquired Intermedt Medizin & Technik GmbH which is allowing the company to complete its extensive portfolio as a systems provider for extracorporeal blood treatment (dialysis).

  • Asahi Kasei Corporation has obtained the approval for manufacturing and selling Cresemba Capsule 100 mg and Cresemba Intravenous Infusion 200 mg in Japan for the treatment of the fungal infections of aspergillosis, mucormycosis, and cryptococcosis.


Author Credits:  Radhika Pawar


  • Report ID: 3372
  • Published Date: Jul 23, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of expanded hemodialysis therapy is assessed at USD 87.62 Billion.

The expanded hemodialysis therapy market size was valued at USD 83.92 Billion in 2023 and is anticipated to reach USD 156.3 Billion by the end of 2036, registering around 4.9% CAGR during the forecast period i.e., between 2024-2036. The major growth drivers for the market are the growing prevalence of diabetes and hypertension and increasing technological advancements to develop innovative therapies.

North America is poised to dominate majority industry share of about 35% by 2036, propelled by rising healthcare expenditure, growing disposable income, and rising demand for the development of new products.

B. Braun Melsungen AG, Asahi Kasei Corporation, Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA, Nikkiso Co., Ltd., Nipro Corporation, NxStage Medical, Inc., Cantel Medical Corp., Satellite Healthcare, Inc., MEDIVATORS, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying